Editorial: Perspectives in virus and host: 2025

Front Cell Infect Microbiol. 2026 Apr 22:16:1849483. doi: 10.3389/fcimb.2026.1849483. eCollection 2026.

Yu Yang^#¹, Severino Jefferson Ribeiro da Silva^#², Dhaneshwar Kumar^#³, Kanchan Bhardwaj^{4

5}, Yong Qi^{1

6

7}

¹ Huadong Research Institute for Medicine and Biotechniques, Nanjing, Jiangsu, China.
² Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.
³ Immunoregulation Section, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MD, United States.
⁴ Department of Biotechnology, Manav Rachna International Institute of Research Studies, Faridabad, Haryana, India.
⁵ Regional Centre for Biotechnology, NCR Biotech Science Cluster, Faridabad, Haryana, India.
⁶ School of Engineering, China Pharmaceutical University, Nanjing, China.
⁷ School of Life Science, Xuzhou Medical University, Xuzhou, China.

^# Contributed equally.

No abstract available

Keywords: emerging viral threats; global public health; host-directed therapy; viral pathogenesis; virus-host interactions.

Publication types